Check out which companies are making headlines before the bell:
Wal-Mart (WMT)-The world's biggest retailer matched estimates with quarterly profit of $1.21 per share, while revenue was slightly above consensus. Wal-Mart cut its full-year forecast, and said performance in its U.S. Walmart and Sam's Club locations were not as good as it would have liked. The lowered forecast is the result of higher employee health care costs and increased investment in the company's online business.
Kohl's (KSS)-Kohl's earned $1.13 per share for its second quarter, beating estimates six cents, though revenue was slightly shy of forecasts. Comparable store sales fell more than expected during the quarter, though Kohl's points out that it had positive same-store sales during the month of July.
Progressive (PGR)-The insurance company's stock was upgraded to "buy" from "neutral" at Citigroup, noting an improvement in Progressive's underwriting spreads.
Keurig Green Mountain (GMCR)-The maker of single-serve brewing systems announced a 9 percent price increase for its pods and bulk coffee products, effective November 3.
Cisco Systems (CSCO)-The networking equipment maker reported fiscal fourth quarter profit of 55 cents per share, excluding certain items, two cents above estimates. Revenue was also above consensus, but the company also announced current quarter revenue would be flat to slightly higher, and said it would cut 6,000 jobs or eight percent of its workforce.
Amgen (AMGN)-Amgen said its Kyprolis drug did not improve survival rates in a trial of patients suffering from advanced multiple myeloma. The biotech giant also said the trial showed an increase in negative effects affecting kidney function compared to a control group.
Noodles & Co (NDLS)-Noodles missed estimates by two cents with second quarter earnings of 12 cents per share, excluding certain items, with revenue also falling below analyst forecasts. The restaurant chain cut its full-year outlook, although it did say it had a "solid finish" to the second quarter and a positive start to the current quarter.
Tekmira Pharmaceuticals (Toronto Stock Exchange: TKM-CA)-Tekmira said it was discussing options for distributing its experimental Ebola treatment with various governments around the world, noting the difficulties that stem from its status as a yet-to-be-approved drug.
General Electric (GE)-GE is in talks with Sweden's Electrolux and consumer product development startup Quirky to sell its household appliances business, according to Bloomberg. The business could reportedly bring in as much as $2 billion.
-By CNBC's Peter Schacknow
Questions? Comments? Email us at email@example.com